期刊文献+

大片吸虫α-微管蛋白基因的克隆表达及免疫反应性的研究 被引量:3

Cloning,expression and immune-reactivity of α-tubulin gene of Fasciola gigantica
原文传递
导出
摘要 为鉴定大片吸虫α-微管蛋白基因(FgAT),并分析其作为诊断抗原的可行性,根据肝片吸虫的基因组及转录组数据设计α-微管蛋白基因的扩增引物,以大片吸虫总RN A为模板,通过RT-PCR获得大片吸虫的FgAT基因;对其进行生物信息学分析及鉴定,然后构建pGEX-6P-1(+)-FgAT重组表达载体,在大肠杆菌BL21(DE3)中进行诱导表达,再对纯化的目的蛋白进行SDS-PAGE和Western-blot分析。结果表明,大片吸虫FgAT基因的大小为1 356 bp,编码452个氨基酸残基。生物信息学分析表明,FgAT二级结构预测以无规卷曲为主,抗原表位在整个序列中均有存在。优化后的α-微管蛋白为可溶性表达,Western-blot分析结果表明其具有良好的免疫反应性。本研究首次克隆并鉴定了大片吸虫α-微管蛋白基因,表达的重组蛋白具有良好的免疫反应性,该蛋白是潜在的大片吸虫诊断靶标。 To identify α-tubulin gene of Fasciola gigantica(FgAT) and analyze its feasibility as a diagnostic antigen,the specific primers were designed according to the genome and transcriptome data of F.hepatica,and the complete ORF was amplified from total RNA by RT-PCR.The fragment including the FgAT complete ORF was cloned into the p GEX-6P-1 expression vector.The α-tubulin fusion protein was expressed in Escherichia coli and immune-reactivity was tested by Western-blot.The results showed thatα-tubulin gene sequence contained an ORF of 1 356 bp,encoding a protein of 452 amino acids.Bioinformatics analysis showed that the secondary structure of Fg AT was mainly regulated by random coil,and the antigen epitopes were present in the whole sequence.Western-blot using rabbit antibodies against F.gigantica excretory and secretory products(FgESPs) indicated good immune-reactivity.This study cloned and expressed the fragment α-tubulin for the first time,and the recombinant protein has immune-reactivity,indicating that F.gigantica α-tubulin may represent a candidate antigen for the diagnosis ofF.gigantica infection.
出处 《中国兽医科学》 CAS CSCD 北大核心 2017年第4期495-499,共5页 Chinese Veterinary Science
基金 国家重点基础研究发展计划(973)项目(2015CB150300)
关键词 大片吸虫 α-微管蛋白基因 表达 诊断候选抗原 Fasciola gigantica α-tubulin gene expression diagnostic candidate antigen
  • 相关文献

参考文献3

二级参考文献23

  • 1朱红杰,张彦华,张亿虹,闫玉清.胰岛素样生长因子的研究进展[J].黑龙江医药,2007,20(3):200-203. 被引量:17
  • 2Yadav S C,Sharma R L,Kalicharan A et al.Primaryexperimental infection of riverine buffaloes with Fasciola gigantica[J].Vet Parasitol,1999,82(4):285~296.
  • 3DEL BRUTTO O H,GARCA H H.Taenia solium cysticercosisThe lessons of history[J].J Neurol Sci,2015,359(1-2):392-395.
  • 4PLANCARTE A,FLISSER A,GAUCI C G,et al.Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens[J].Int J Parasitol,1999,29(4):643-647.
  • 5DOERIG C.Protein kinases as targets for anti-parasitic chemotherapy[J].Biochim Biophys Acta,2004,1697(1):155-168.
  • 6HANKS S K,QUINN A M,HUNTER T.The protein kinase family:conserved features and deduced phylogeny of the catalytic domains[J].Science,1988,241(4861):42-52.
  • 7TAYLOR S S,KIM C,CHENG C Y,et al.Signaling through c AMP and c AMP-dependent protein kinase:diverse strategies for drug design[J].Biochim Biophys Acta,2008,1784(1):16-26.
  • 8HANKS S K.Genomic analysis of the eukaryotic protein kinase superfamily:a perspective[J].Genome Biol,2003,4(5):111.
  • 9EGLEN R M,REISINE T.The current status of drug discovery against the human kinome[J].Assay Drug Dev Technol,2009,7(1):22-43.
  • 10DIAZ-MASMELA Y,FRAGOSO G,AMBROSIO J R,et al.Immunodiagnosis of porcine cysticercosis:Identification of candidate antigens through immunoproteomics[J].Vet J,2013,198(3):656-660.

共引文献12

同被引文献20

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部